Equities analysts expect that Metlife Inc (NYSE:MET) will announce $16.35 billion in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Metlife’s earnings, with the highest sales estimate coming in at $17.21 billion and the lowest estimate coming in at $15.49 billion. Metlife reported sales of $16.92 billion during the same quarter last year, which indicates a negative year over year growth rate of 3.4%. The firm is expected to report its next quarterly earnings report on Wednesday, November 4th.
According to Zacks, analysts expect that Metlife will report full-year sales of $61.76 billion for the current fiscal year, with estimates ranging from $60.68 billion to $63.86 billion. For the next fiscal year, analysts expect that the firm will report sales of $67.05 billion, with estimates ranging from $66.86 billion to $67.16 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Metlife.
Metlife (NYSE:MET) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.83 EPS for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.07). Metlife had a net margin of 10.65% and a return on equity of 7.71%.
NYSE MET traded up $0.12 on Friday, reaching $37.63. 8,554,093 shares of the company’s stock traded hands, compared to its average volume of 6,760,743. The company has a debt-to-equity ratio of 0.20, a current ratio of 0.16 and a quick ratio of 0.16. Metlife has a 12 month low of $22.85 and a 12 month high of $53.28. The stock has a market cap of $34.16 billion, a PE ratio of 4.89, a P/E/G ratio of 2.21 and a beta of 1.30. The stock has a 50-day simple moving average of $38.52 and a 200 day simple moving average of $35.84.
The business also recently declared a quarterly dividend, which was paid on Monday, September 14th. Investors of record on Tuesday, August 4th were issued a $0.46 dividend. This represents a $1.84 annualized dividend and a yield of 4.89%. The ex-dividend date of this dividend was Monday, August 3rd. Metlife’s dividend payout ratio (DPR) is currently 30.11%.
In related news, Director Catherine R. Kinney sold 3,657 shares of Metlife stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $39.50, for a total value of $144,451.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.07% of the company’s stock.
A number of institutional investors have recently made changes to their positions in MET. Public Employees Retirement Association of Colorado lifted its position in Metlife by 15.4% during the first quarter. Public Employees Retirement Association of Colorado now owns 146,582 shares of the financial services provider’s stock valued at $4,481,000 after buying an additional 19,525 shares during the period. Nissay Asset Management Corp Japan ADV raised its position in shares of Metlife by 0.6% in the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 92,011 shares of the financial services provider’s stock worth $2,813,000 after purchasing an additional 569 shares during the last quarter. Chicago Equity Partners LLC raised its position in shares of Metlife by 3.0% in the 1st quarter. Chicago Equity Partners LLC now owns 116,690 shares of the financial services provider’s stock worth $3,567,000 after purchasing an additional 3,400 shares during the last quarter. Fort Washington Investment Advisors Inc. OH raised its position in shares of Metlife by 8.5% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 183,606 shares of the financial services provider’s stock worth $5,613,000 after purchasing an additional 14,406 shares during the last quarter. Finally, Rhumbline Advisers raised its position in shares of Metlife by 0.3% in the 1st quarter. Rhumbline Advisers now owns 1,404,907 shares of the financial services provider’s stock worth $42,948,000 after purchasing an additional 4,741 shares during the last quarter. 74.92% of the stock is owned by institutional investors and hedge funds.
Metlife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Further Reading: Profit Margin
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.